ALR Technologies SG (ALRTF) Operating Expenses (2024 - 2025)
ALR Technologies SG posted quarterly Operating Expenses of $620706.0 for Q2 2025, down 23.68% year-on-year from $813331.0 in Q2 2024, and down 23.68% on a QoQ basis from $813331.0 in Q2 2024.
ALR Technologies SG (ALRTF) has 2 years of Operating Expenses data on file, last reported at $620706.0 in Q2 2025.
- For the quarter ending Q2 2025, Operating Expenses fell 23.68% year-over-year to $620706.0; the trailing twelve-month figure through Dec 2025 stood at $1.4 million (up 76.32% YoY), and the FY2025 full-year result was $2.9 million, down 15.55% from the prior year.
- Operating Expenses for Q2 2025 stood at $620706.0, down from $813331.0 in the prior quarter.
- Across five years, Operating Expenses topped out at $813331.0 in Q2 2024 and bottomed at $620706.0 in Q2 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Opex (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 9.82 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 2.87 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 3.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 2.51 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 822.60 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | -668.50 Mn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 495.00 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 1.46 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 380.30 Mn |
| 10 | ALR Technologies SG | - | - | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | 620,706.00 |
| Jun 30, 2024 | 813,331.00 |